NetworkNewsBreaks – ChineseInvestors.com, Inc. (
Post# of 346
ChineseInvestors.com (OTCQB: CIIX), through its CBD Biotechnology Co. Ltd. subsidiary, sees an approaching boost in industrial hemp cannabidiol (“CBD”) sales after entering a key distribution agreement. Warren Wang, Chief Executive Officer of ChineseInvestors.com, believes CBD hemp sales in China are driving its product revenue growth. A recent article discussing the company reads: “The outlook according to Wang is positive, thanks to the evolving business, regulatory and political landscapes of the Chinese industrial hemp CBD market. The company plans to increase its product distribution in both the U.S. and Chinese markets. … To widen the distribution network for its industrial hemp CBD products, ChineseInvestors.com, through subsidiary CBD Biotechnology Co. Ltd., signed an agreement with Alibaba Group’s Tmall. This will see the subsidiary leverage Tmall’s e-commerce marketplace to reach a wider market.”
Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer